XML 12 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 9,840 $ 4,016
General and administrative 6,444 4,114
Total operating expenses 16,284 8,130
Loss from operations (16,284) (8,130)
Other income (expense):    
Grant income 22  
Interest income 1,322 934
Interest expense (1,564) (306)
Change in fair value of warrant liabilities 7,643 14,881
Total other income, net 7,423 15,509
Net income (loss) and comprehensive income (loss) $ (8,861) $ 7,379
Net income (loss) per share, basic $ (0.14) $ 0.15
Net income (loss) per share, diluted $ (0.14) $ 0.13
Weighted-average common shares outstanding, basic 62,361,897 50,482,278
Weighted-average common shares outstanding, diluted 62,361,897 54,765,842